$1.77
1.12% today
Nasdaq, Dec 30, 09:48 pm CET
ISIN
CA88338H1001
Symbol
THTX
Sector
Industry

Theratechnologies Inc. Target price 2024 - Analyst rating & recommendation

Theratechnologies Inc. Classifications & Recommendation:

Buy
75%
Hold
25%

Theratechnologies Inc. Price Target

Target Price $4.73
Price $1.79
Potential
Number of Estimates 2
2 Analysts have issued a price target Theratechnologies Inc. 2025 . The average Theratechnologies Inc. target price is $4.73. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 4 analysts: 3 Analysts recommend Theratechnologies Inc. to buy, 1 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Theratechnologies Inc. stock has an average upside potential 2025 of . Most analysts recommend the Theratechnologies Inc. stock at Purchase.

Sales and Margin forecast 2024, 2025 to 2028

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Nov '23 2024
Estimates
Revenue Million $ 81.76 83.79
2.12% 2.48%
EBITDA Margin -7.20% 21.56%
79.22% 399.28%
Net Margin -51.18% 1.92%
55.00% 103.75%

4 Analysts have issued a sales forecast Theratechnologies Inc. 2024 . The average Theratechnologies Inc. sales estimate is

$83.8m
Unlock
. This is
0.63% lower
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$84.7m 0.41%
Unlock
, the lowest is
$83.2m 1.27%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2023 $81.8m 2.12%
2024
$83.8m 2.48%
Unlock
2025
$87.8m 4.81%
Unlock
2026
$95.5m 8.76%
Unlock
2027
$107m 12.02%
Unlock
2028
$122m 13.79%
Unlock

2 Analysts have issued an Theratechnologies Inc. EBITDA forecast 2024. The average Theratechnologies Inc. EBITDA estimate is

$18.1m
Unlock
. This is
25.35% higher
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
$18.2m 26.41%
Unlock
, the lowest is
$17.9m 24.29%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2023 $-5.9m 78.77%
2024
$18.1m 406.66%
Unlock
2025
$19.3m 6.83%
Unlock
2026
$29.4m 52.24%
Unlock
2027
$36.8m 25.34%
Unlock
2028
$47.5m 28.91%
Unlock

EBITDA Margin

2023 -7.20% 79.22%
2024
21.56% 399.28%
Unlock
2025
21.97% 1.90%
Unlock
2026
30.76% 40.01%
Unlock
2027
34.41% 11.87%
Unlock
2028
38.99% 13.31%
Unlock

4 Theratechnologies Inc. Analysts have issued a net profit forecast 2024. The average Theratechnologies Inc. net profit estimate is

$1.6m
Unlock
. This is
138.91% higher
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$2.8m 166.70%
Unlock
, the lowest is
$460k 111.12%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2023 $-41.8m 54.04%
2024
$1.6m 103.85%
Unlock
2025
$5.9m 263.98%
Unlock
2026
$11.3m 92.32%
Unlock
2027
$19.1m 69.30%
Unlock
2028
$27.8m 45.81%
Unlock

Net Margin

2023 -51.18% 55.00%
2024
1.92% 103.75%
Unlock
2025
6.68% 247.92%
Unlock
2026
11.79% 76.50%
Unlock
2027
17.84% 51.31%
Unlock
2028
22.85% 28.08%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2024, 2025 to 2028

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Nov '23 2024
Estimates
Earnings Per Share $ -0.91 0.04
54.04% 104.40%
P/E 51.14
EV/Sales 0.74

4 Analysts have issued a Theratechnologies Inc. forecast for earnings per share. The average Theratechnologies Inc. <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is

$0.04
Unlock
. This is
144.44% higher
Unlock
than earnings per share in the financial year 2023. The highest <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS forecast is
$0.06 166.67%
Unlock
, the lowest is
$0.01 111.11%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2023 $-0.91 54.04%
2024
$0.04 104.40%
Unlock
2025
$0.13 225.00%
Unlock
2026
$0.25 92.31%
Unlock
2027
$0.42 68.00%
Unlock
2028
$0.61 45.24%
Unlock

P/E ratio

Current -18.88 1,330.30%
2024
51.14 370.87%
Unlock
2025
14.04 72.55%
Unlock
2026
7.31 47.93%
Unlock
2027
4.31 41.04%
Unlock
2028
2.96 31.32%
Unlock

Based on analysts' sales estimates for 2024, the Theratechnologies Inc. stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of

and an <a href=https://blog.stocksguide.com/knowledge/price-sales-ratio-simply-explained>P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 0.74 20.43%
2024
0.74 0.46%
Unlock
2025
0.71 4.59%
Unlock
2026
0.65 8.05%
Unlock
2027
0.58 10.73%
Unlock
2028
0.51 12.11%
Unlock

P/S ratio

Current 0.51 6.69%
2024
0.52 0.62%
Unlock
2025
0.49 4.58%
Unlock
2026
0.45 8.05%
Unlock
2027
0.40 10.74%
Unlock
2028
0.36 12.13%
Unlock

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today